Skip to content

ICL Group

US · ICL #1851 by market cap Listed 1970
5.08 0.00 0.00%
Live - 5344 symbols - heartbeat 95s ago · 2026-10-08 07:56
Pre-market 4.99 -1.77%
After-hours 5.08 0.00%
Overnight 5.07 -0.20%
Market cap
6.56B
P/B
1.07
EPS
0.18
Reader sentiment Are you bullish or bearish on ICL?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.4
    Market Newswire · 2026/4/3
  • Rating change
    Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6.15
    Market Newswire · 2026/1/14
  • Rating change
    Barclays Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $7
    Market Newswire · 2026/5/18
  • Rating change
    BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6.75
    Market Newswire · 2025/11/13
  • Rating change
    Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.8
    Market Newswire · 2025/11/25
  • Rating change
    BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $6.5
    Market Newswire · 2026/5/20
  • Rating change
    Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.6
    Market Newswire · 2026/7/22
  • Rating change
    Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $5.6
    Market Newswire · 2026/2/27
  • Rating change
    Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $7
    Market Newswire · 2025/8/13
  • KingMed Diagnostics (603882): The ICL industry is gradually stabilizing, and the company's profitability has improved significantly.
    Citic Securities · 2026/9/30
  • Rating change
    Barclays Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6
    Market Newswire · 2026/7/27
  • Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6
    Market Newswire · 2026/8/11
  • ICL Group Q2 Adj. EPS $0.12 Beats $0.10 Estimate, Sales $2.135B Beat
    Benzinga · 2026/8/5
  • Company notice
    ICL Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Harel Insurance Investments & Financial Services Ltd.(5.4%)
    SEC · 2024/1/30
  • Company notice
    ICL Group | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altshuler-Shaham Ltd.(5.0%),Gilad Altshuler(5.0%), etc.
    SEC · 2023/1/17
  • Company notice
    ICL Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Phoenix Holdings Ltd.(5.02%)
    SEC · 2023/12/28
  • Company notice
    ICL Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Israel Corporation Ltd. : 000000000(43.98%)
    SEC · 2023/2/4
  • Morgan Stanley Initiates ICL Group(ICL.US) With Hold Rating, Announces Target Price $5.75
    Market Newswire · 2026/8/10
  • BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6
    Market Newswire · 2026/8/6
  • Company notice
    Imperium Crown: Asset Acquisitions and Disposals-Dissolution of Dormant Wholly-Owned Subsidiary - ICL Land Sdn. Bhd.
    SGX · 2025/6/18

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:56:40 · For reference only, not investment advice and not tailored to your situation.